WEIS MARKETS REPORTS SECOND QUARTER 2026 RESULTS
Weis Markets (NYSE: WMK) reported Q2 2026 total revenue of $1.28 billion, up 4.6% from $1.22 billion in Q2 2025. Comparable store sales rose 2.3% year over year. Net income fell to $22.86 million, down 9.6%, and EPS was $0.92. Pharmacy revenue faced Medicare pricing headwinds. A $0.34 quarterly dividend was declared.
How this was made
The 30-second read
Why it matters
Traders will likely focus on the divergence between improving revenue/comps and declining net income/EPS, and on the magnitude of pharmacy pricing headwinds cited for both the quarter and year-to-date.
Market read
A fresh earnings release with quantified pharmacy pricing headwinds and a dividend declaration, creating a near-term catalyst for WMK positioning.
What to watch
Two-year stacked comparable store sales improved, and management highlighted stronger performance at newer stores, which could partially offset near-term pharmacy margin pressure.
Background
Weis Markets released its 13-week Q2 2026 and 26-week year-to-date results ended June 27, 2026, including pharmacy-specific headwinds tied to IRA Medicare pricing.
Ticker impact
Weis Markets reported Q2 2026 revenue of $1.28B (+4.6%) and EPS of $0.92, down 4 cents year over year.
Likely modest near-term volatility as traders weigh revenue/comps strength against EPS decline and pharmacy headwinds.
The article provides specific Q2 and YTD financial datapoints plus a concrete driver for pharmacy weakness (IRA Medicare maximum fair price provisions effective Jan 1, 2026).
Market effects
Signals ongoing pressure in pharmacy reimbursement economics for grocery retailers with Medicare Part D exposure under the IRA pricing rules.
May influence sentiment toward Mid-Atlantic grocery peers if investors extrapolate similar pharmacy headwinds and value-driven demand.
Limited, as the disclosure is company-specific and not tied to global macro or supply shocks.
Counterpoint
The EPS decline may be more about pharmacy reimbursement timing and pricing mechanics than underlying demand weakness, so the market may over-penalize the stock.
Key entities
- companyWeis Markets, Inc.
Mid-Atlantic grocery retailer reporting Q2 2026 results and a quarterly dividend.
- policyInflation Reduction Act (IRA) Medicare maximum fair price provisions
Pricing provisions effective Jan 1, 2026 that the company cites as headwinds to pharmacy revenue.
- governanceWeis Markets Board of Directors
Declared a quarterly cash dividend of $0.34 per share payable Aug. 10, 2026.
